Sam Samad
CIK: 0001694295
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Oct 21, 2026DGX
QUEST DIAGNOSTICS INC
Award(A)Direct90 shares at avg. $235.94$21K - Jul 22, 2026DGX
QUEST DIAGNOSTICS INC
Award(A)Direct102 shares at avg. $206.81$21K - May 12, 2026IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectDeferred Stock Unit
234 shares- - May 12, 2026IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectNon-Qualified Stock Option (right-to-buy)
525 shares- - Apr 20, 2026DGX
QUEST DIAGNOSTICS INC
Award(A)Direct108 shares at avg. $194.70$21K - Mar 4, 2026DGX
QUEST DIAGNOSTICS INC
Award(A)Direct13.9K shares at avg. $204.86$2.9M - Mar 4, 2026DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct7.7K shares at avg. $204.86$1.6M - Mar 2, 2026DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct869 shares at avg. $204.86$178K - Feb 18, 2026DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct855 shares at avg. $210.01$180K - Feb 18, 2026DGX
QUEST DIAGNOSTICS INC
Award(A)Direct4K shares- - Feb 18, 2026DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct1K shares at avg. $206.99$209K - Jan 28, 2026DGX
QUEST DIAGNOSTICS INC
Award(A)Direct69 shares at avg. $183.51$13K - Oct 21, 2025DGX
QUEST DIAGNOSTICS INC
Award(A)Direct68 shares at avg. $189.08$13K - Jul 21, 2025DGX
QUEST DIAGNOSTICS INC
Small Acquisition(L)Direct72 shares at avg. $167.50$12K - Jul 16, 2025DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct850 shares at avg. $169.01$144K - May 7, 2025IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectDeferred Stock Unit
257 shares- - May 7, 2025IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectNon-Qualified Stock Option (right-to-buy)
600 shares- - Apr 21, 2025DGX
QUEST DIAGNOSTICS INC
Small Acquisition(L)Direct74 shares at avg. $164.42$12K - Mar 4, 2025DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct7.7K shares at avg. $173.74$1.3M - Mar 4, 2025DGX
QUEST DIAGNOSTICS INC
Award(A)Direct13.9K shares at avg. $173.74$2.4M - Feb 26, 2025DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct869 shares at avg. $171.75$149K - Feb 19, 2025DGX
QUEST DIAGNOSTICS INC
Tax Payment(F)Direct1K shares at avg. $169.71$175K - Feb 12, 2025DGX
QUEST DIAGNOSTICS INC
Award(A)Direct4.5K shares- - Jan 29, 2025DGX
QUEST DIAGNOSTICS INC
Small Acquisition(L)Direct35 shares at avg. $158.04$6K - Oct 21, 2024DGX
QUEST DIAGNOSTICS INC
Small Acquisition(L)Direct37 shares at avg. $149.37$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 | DGX QUEST DIAGNOSTICS INC | Award(A) | 90 | $235.94 | $21,235 | Direct |
| Jul 22, 2026 | DGX QUEST DIAGNOSTICS INC | Award(A) | 102 | $206.81 | $21,094 | Direct |
| May 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Deferred Stock Unit | 234 | - | - | Direct |
| May 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Non-Qualified Stock Option (right-to-buy) | 525 | - | - | Direct |
| Apr 20, 2026 | DGX QUEST DIAGNOSTICS INC | Award(A) | 108 | $194.70 | $21,027 | Direct |
| Mar 4, 2026 | DGX QUEST DIAGNOSTICS INC | Award(A) | 13,947 | $204.86 | $2,857,182 | Direct |
| Mar 4, 2026 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 7,720 | $204.86 | $1,581,519 | Direct |
| Mar 2, 2026 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 869 | $204.86 | $178,023 | Direct |
| Feb 18, 2026 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 855 | $210.01 | $179,559 | Direct |
| Feb 18, 2026 | DGX QUEST DIAGNOSTICS INC | Award(A) | 3,965 | - | $0 | Direct |
| Feb 18, 2026 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 1,010 | $206.99 | $209,060 | Direct |
| Jan 28, 2026 | DGX QUEST DIAGNOSTICS INC | Award(A) | 69 | $183.51 | $12,662 | Direct |
| Oct 21, 2025 | DGX QUEST DIAGNOSTICS INC | Award(A) | 68 | $189.08 | $12,858 | Direct |
| Jul 21, 2025 | DGX QUEST DIAGNOSTICS INC | Small Acquisition(L) | 72 | $167.50 | $12,060 | Direct |
| Jul 16, 2025 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 850 | $169.01 | $143,659 | Direct |
| May 7, 2025 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Deferred Stock Unit | 257 | - | - | Direct |
| May 7, 2025 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Non-Qualified Stock Option (right-to-buy) | 600 | - | - | Direct |
| Apr 21, 2025 | DGX QUEST DIAGNOSTICS INC | Small Acquisition(L) | 74 | $164.42 | $12,167 | Direct |
| Mar 4, 2025 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 7,684 | $173.74 | $1,335,018 | Direct |
| Mar 4, 2025 | DGX QUEST DIAGNOSTICS INC | Award(A) | 13,884 | $173.74 | $2,412,206 | Direct |
| Feb 26, 2025 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 869 | $171.75 | $149,251 | Direct |
| Feb 19, 2025 | DGX QUEST DIAGNOSTICS INC | Tax Payment(F) | 1,031 | $169.71 | $174,971 | Direct |
| Feb 12, 2025 | DGX QUEST DIAGNOSTICS INC | Award(A) | 4,538 | - | - | Direct |
| Jan 29, 2025 | DGX QUEST DIAGNOSTICS INC | Small Acquisition(L) | 35 | $158.04 | $5,531 | Direct |
| Oct 21, 2024 | DGX QUEST DIAGNOSTICS INC | Small Acquisition(L) | 37 | $149.37 | $5,527 | Direct |
1-25 of 25 transactions
About SAMAD SAM
SAMAD SAM (SEC CIK 0001694295) files insider reports with the SEC as Executive Vice President & CFO of QUEST DIAGNOSTICS INC (DGX) and Director of IDEXX LABORATORIES INC /DE (IDXX).
Signal8 holds 18 ownership filings by SAMAD SAM, all Form 4s, filed between Oct 25, 2024 and Oct 23, 2026. Those filings report 25 transactions, from Oct 21, 2024 to Oct 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SAMAD SAM's filings is in SECAUCUS, NJ.
Recent filings by SAMAD SAM
- Oct 21, 2026: Grant or award of DGX shares (Form 4, code A).
- Jul 22, 2026: Grant or award of DGX shares (Form 4, code A).
- May 12, 2026: Grants or awards of IDXX derivative securities (2 lines, Form 4, code A).
- Apr 20, 2026: Grant or award of DGX shares (Form 4, code A).
- Mar 4, 2026: Grant or award of DGX shares (Form 4, code A).
Other insiders filing for QUEST DIAGNOSTICS INC (DGX)
- PFEIFFER GARY M, Director
- CARTER ROBERT B, Director
- Gregg Vicky B, Director
- KUPPUSAMY KARTHIK, SVP, Clinical Solutions
- Lassiter Wright III, Director
- Plewman Patrick, SVP for Diagnostic Services